One of the innovative aspects of the Center application is the ability to examine the effects of pharmacological agents across three platforms: i) animal models which allow early screening and exploration of neuronal and cellular mechanisms;ii) non-clinical human model which provide opportunity for ascertaining an early human signal of potential efficacy of a compound for cognition and/or negative symptom phenotypes in the absence of the usual confounds associated with clinical cohorts (e.g., chronicity, psychosis, antipsychotic drugs);and iii) clinical trial confirming the validity of this approach. The Research Methods Core is responsible for developing a battery of biomarkers to be used in human studies (Projects #2 and #3). In addition, the Core will provide expertise, staff and facilities in order for the Projects #2 and #3 can carry out the proposed drug studies. The Core will develop and provide analytic strategy that evaluates effects of drugs within each of the 3 projects (1 preclinical and 2 human), and relates effects across the three set of studies using the same drugs. The Research Method Core will maintain an extensive interaction with the Pre-clinical Studies Core. The Core will interact with the Operations and Clinical Assessment Core around data management, and issues related to design and statistics.
Showing the most recent 10 out of 22 publications
